Medical Devices industry M&A deals total $3.3bn in US in January 2022

Total medical devices industry M&A deals worth $3.3bn were announced in the US in January 2022, with Owens & Minor’s $1.6bn acquisition of Apria being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked a decrease of 91.9% over the previous month of $40.38bn and a drop of 58.8% when compared with the last 12-month average of $7.91bn.

The US held a 98.79% share of the global medical devices industry M&A deal value that totalled $3.3bn in January 2022.

In terms of M&A deal activity, the US recorded 31 deals during January 2022, marking a decrease of 13.89% over the previous month and a rise of 29.17% over the 12-month average.

US medical devices industry M&A deals in January 2022: Top deals

The top five medical devices industry M&A deals accounted for 95.3% of the overall value during January 2022.

The combined value of the top five medical devices M&A deals stood at $3.1bn, against the overall value of $3.3bn recorded for the month.

The top five medical devices industry M&A deals of January 2022 tracked by GlobalData were:

1) Owens & Minor $1.6bn acquisition deal with Apria

2) The $623m acquisition of GeneDX by Sema4 OpCo

3) ConvaTec Group $450m acquisition deal with Triad Life Sciences

4) The $240m acquisition of MyChem by Maravai LifeSciences Holdings

5) Exact Sciences $190m acquisition deal with PreventionGenetics